|
|
||||||||
1 Department of Surgery (Cardiac and Thoracic), University of Chicago, Chicago 60637; 2 The Heart Institute for Children, Hope Children's Hospital, OakLawn 60453; and Departments of 3 Physiology and Biophysics and 4 Medicine (Cardiology), University of Illinois at Chicago, Chicago, Illinois 60612
Serum response factor
(SRF) has been shown to play a key role in cardiac cell growth and
muscle gene regulation. To understand the role of SRF in heart failure,
we compared its expression pattern between control and failing human
heart samples. Western blot analysis of control samples showed
expression of four different isoforms of SRF, with ~67-kDa
full-length SRF being the predominant isoform. Interestingly, in
failing hearts we found robust expression of a low-molecular-mass
(~52 kDa) SRF isoform, accompanied by decreased expression of
full-length SRF. By RT-PCR and Southern blot analyses, we
characterized this ~52-kDa SRF isoform as being encoded by an
alternatively spliced form of SRF lacking exons 4 and 5 of the SRF
primary RNA transcript (SRF-
4,5 isoform). We cloned SRF-
4,5 cDNA
and showed that overexpression of this isoform into cells inhibits
SRF-dependent activation of cardiac muscle genes. These results suggest
that expression of SRF-
4,5 in failing hearts may in part contribute
to impaired cardiac gene expression and consequently to the
pathogenesis of heart failure.
serum response factor; cardiac hypertrophy; cardiac gene regulation; alternative gene splicing
This article has been cited by other articles:
![]() |
A. Zhang, J. J. David, S. V. Subramanian, X. Liu, M. D. Fuerst, X. Zhao, C. V. Leier, C. G. Orosz, R. J. Kelm Jr., and A. R. Strauch Serum response factor neutralizes Pur{alpha}- and Pur{beta}-mediated repression of the fetal vascular smooth muscle {alpha}-actin gene in stressed adult cardiomyocytes Am J Physiol Cell Physiol, March 1, 2008; 294(3): C702 - C714. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.C. T. Pipes, E. E. Creemers, and E. N. Olson The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes & Dev., June 15, 2006; 20(12): 1545 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rene, M. Taulan, F. Iral, J. Doudement, A. L'Honore, C. Gerbon, J. Demaille, M. Claustres, and M.-C. Romey Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway Nucleic Acids Res., September 16, 2005; 33(16): 5271 - 5290. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Davis, J. B Pillai, M. Gupta, and M. P. Gupta Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of {alpha}-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1477 - H1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Pillai, H. M. Russell, J. Raman, V. Jeevanandam, and M. P. Gupta Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H486 - H496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parlakian, D. Tuil, G. Hamard, G. Tavernier, D. Hentzen, J.-P. Concordet, D. Paulin, Z. Li, and D. Daegelen Targeted Inactivation of Serum Response Factor in the Developing Heart Results in Myocardial Defects and Embryonic Lethality Mol. Cell. Biol., June 15, 2004; 24(12): 5281 - 5289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chang, L. Wei, T. Otani, K. A. Youker, M. L. Entman, and R. J. Schwartz Inhibitory Cardiac Transcription Factor, SRF-N, Is Generated by Caspase 3 Cleavage in Human Heart Failure and Attenuated by Ventricular Unloading Circulation, July 29, 2003; 108(4): 407 - 413. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |